(Q37944416)

25 August 2017

title

Restenosis after PCI. Part 2: prevention and therapy (English)

1 reference

25 August 2017

1

J Wouter Jukema

1 reference

25 August 2017

Tarek A N Ahmed

2

1 reference

25 August 2017

Jeffrey J W Verschuren

series ordinal

3

1 reference

25 August 2017

Paul H A Quax

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

11 October 2011

1 reference

Nature Reviews Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

79-90

1 reference

https://scigraph.springernature.com/pub.10.1038/nrcardio.2011.148

25 August 2017

exact match

0 references

cites work

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ s

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Sirolimus: its discovery, biological properties, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Novel high-throughput polymer biocompatibility screening designed for SAR (structure-activity relationship): application for evaluating polymer coatings for cardiovascular drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Patrick Washington Serruys: a view from across the Atlantic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

The bioabsorption process: tissue and cellular mechanisms and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-elutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Coronary stents: looking forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Peri-implant bone formation and implant integration strength of peptide-modified p(AAM-co-EG/AAC) interpenetrating polymer network-coated titanium implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Microfabrication and nanotechnology in stent design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Coronary stent restenosis in patients treated with cilostazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting St

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

PPARgamma and atherosclerosis: effects on cell growth and movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

In-stent restenosis in the drug-eluting stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Drug-eluting stent restenosis the pattern predicts the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Rapamycins: mechanism of action and cellular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Mechanisms of Taxol resistance related to microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Treatment of drug-eluting stent restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Treatment of drug-eluting stent restenosis: an emerging challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Restenosis after PCI. Part 1: pathophysiology and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of th

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. An experimental study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Cutting balloon coronary angioplasty--initial clinical experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Experience with revascularization procedures does matter: low volume means worse outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.148

Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis

31 March 2020

1 reference

12 December 2020

The next generation Endeavor Resolute Stent: role of the BioLinx Polymer System.

1 reference

12 December 2020

Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions

1 reference

12 December 2020

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent

1 reference

12 December 2020

Nanoparticulate carriers for the treatment of coronary restenosis

1 reference

12 December 2020

Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial

1 reference

12 December 2020

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

1 reference

12 December 2020

10.1038/NRCARDIO.2011.148

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1037998078

0 references

1 reference